8/8/2019 My Thesis Data

1/8

8/8/2019 My Thesis Data

2/8

Lab Investigations Tumor Markers USG findings- Mass

Total Bilirubin (mol/L) CEA

394 180.8 141.3 0 4.3 Present Present

361 448.8 371.5 0 15.8 Present Present

946 229 164.6 199 91.4 Present Present

315 190.6 152.7 0 46.2 Present Present

308 433.7 320.7 0 583.9 Present Present

227 189 121 0 1000 Present Present

136 102.7 75.6 9.62 1000 Present Present

1416 461.4 424 25.4 1000 Present Present

677 365.1 269.2 1.9 1000 Present Present

697 164.7 117.2 2.2 140.8 Present Present

143 244.1 209.4 Present Present

529 276.6 204.9 Present Present

224 136.5 119.8 5.6 1000 Present Present

AlkalinePhosphatase(U/L)

Direct Bilirubin(mol/L)

CA 19-9(

8/8/2019 My Thesis Data

3/8

Site NCECT findings Mass Site

IHBD Dilatation

Yes Yes Present Present Yes Yes

Yes Yes Present Present Yes Yes

Yes Present Present

Yes Present Present Yes

Yes Present Present Yes

Yes Present Present Yes

Yes Present Present Yes

Yes Present Present Yes

Yes Present Present Yes Yes

Yes Present Present Yes

Yes Present Present Yes

Yes Present Present Yes

Yes Present Present Yes

HepaticHilum

UpperPart ofCBD

Middlepart ofCBD

LowerPart ofCBD

Present/Absent

HepaticHium

UpperPart ofCBD

MiddlePart ofCBD

Lower partof CBD

8/8/2019 My Thesis Data

4/8

CECT findings

Slightly Significantly Slightly 25

Slightly Significantly Slightly 7

Yes Slightly Significantly Slightly 20

Slightly Significantly Slightly 8

Significantly Significantly Slightly 30

Slightly Slightly Slightly 15

Yes Slightly Significantly Slightly 30

Slightly Significantly Slightly 40

Yes Slightly Significantly Slightly 15

Slightly Significantly Slightly 25

Significantly Significantly Slightly 15

Slightly Significantly Slightly 8

Slightly Significantly Slightly 20

Length of Stricturein mm

Papilla ofthe

duodenum

Arterial PhaseEnhancement

Portal VenousEnhancement

DelayedPhase

Enhancement

8/8/2019 My Thesis Data

5/8

CT Diagnosis Mass

Cholangiocarcinoma Present Present Yes -

Cholangiocarcinoma Present Present Yes

PeriAmpullary Carcinoma 4 Present Present

Cholangiocarcinoma 3 Present Absent Yes

Cholangiocarcinoma 13 Present Present Yes

Cholangiocarcinoma 12 Present Absent Yes

Pancreatic Head Carcinoma 25 Present Absent

Cholangiocarcinoma 30 Present Absent

GB cancer with mets. Pancreatic head 12 Present Absent Yes

Pancreatic Head Carcinoma 20 Present Absent

HCC invading the IHBD of the hepatic hilum 9 Present Present Yes

Cholangiocarcinoma 5 Present Absent Yes

Pancreatic Head Carcinoma 18 Present Absent

Diameter of CBDlumen in mm

PTCfindings

Site ofstricture

IHBDdilatation

Present/Absent

Upper partof CBD

MiddlePart ofCBD

8/8/2019 My Thesis Data

6/8

Mass Mass

- 30 Present

10 Present

Yes 20 Present

10 Present

40 Present

15 Present

Yes 45 Present

Yes 40 Present

15 Present

Yes 40 Present

15 Present

10 Present

Yes 20 Present

Length ofStricture in mm

ERCPfindings

Site ofstricture

Length ofstricture in mm

Surgeryfindings

Lowerpart ofCBD

IHBDdilatation

Present/Absent

Upper partof CBD

MiddlePart ofCBD

Lowerpart ofCBD

Present/Absent

8/8/2019 My Thesis Data

7/8

Site Size of mass

Length in mm

Yes 30 30

Yes 7 7

Yes 150 100

Yes 8 8

Yes 40 40

Yes 12 13

Yes 50 10

Yes 40 15

Yes Yes 30 40

Yes 55 68

Yes 10 15

Yes 90 80

Yes 75 60

UpperPart ofCBD

MiddlePart ofCBD

Lower partof CBD

Breadth inmm

8/8/2019 My Thesis Data

8/8

Biopsy findings

Adenocarcinoma of CHD

Adenocarcinoma of CBD

Adenocarcinoma of Duodenum

Squamous Carcinoma of bile duct

Adenocarcinoma of CBD

Hyperplastic fibrous tissue

Chronic inflmmation of the CBD

Extensive metastases +, no biopsy required

Poorly differentiated adenocarcinoma of GB

Hyperplastic fibrous tissue

HCC invading the bile ducts, extensive mets, no biopsy required

Adenocarcinoma of CHD

Hyperplastic fibrous tissue